Genkyotex S Ais A Biopharmaceutical Company Based In Saint Julien En Genevoisfrancespecializing In Therapies That Inhibit Nadph Oxidasenoxenzymesfounded In 2006 By A Team Of Scientists From Switzerlandthe U S And Japanthe Company Became A Wholly Owned Subsidiary Of Calliditas Therapeutics Ab After An A 88 Million Acquisitiongenkyotex Focuses On Developing Treatments For Diseases Related To Oxidative Stressutilizing Its Proprietary Nox Inhibitor Platform The Company S Lead Productsetanaxibis A Nox1 4 Inhibitor That Has Been Tested In Clinical Trials For Conditions Such As Diabetic Kidney Diseasefibrosisand Atherosclerosisgenkyotex Also Has A Pipeline Of Therapies Aimed At Fibrotic Diseaseschronic Inflammatory Conditionsand Rare Disorderswith Some Receiving Orphan Drug Designationthe Company Is Transitioning From Research And Development To Clinical Developmentleveraging The Resources And Capabilities Of Calliditas Therapeutics To Advance Its Innovative Approaches In Biopharmaceuticals
No conferences found for this company.
| Company Name | Genkyotex Innovation Sas |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
